Large Cap · Healthcare · Medical Instruments & Supplies
Large Cap · Healthcare · Medical Instruments & Supplies
Get the AI take on ALGN
Track it to unlock the price chart, verdict and what could change it.
Free to track. No card required.
Overall score
65/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Lowest
$170
Current price
$181.2
Median target
$209
Highest
$240
Forward P/E
Favorable · 22% below avg
15.29x
Price / sales
Reasonable · Priced reasonably against its revenue
3.11x
Price / FCF
Reasonable · Priced a bit rich against its cash flow
20.33x
EV / EBITDA
Reasonable · Operating earnings make this price a stretch but plausible
13.07x
ROIC
Strong · Comfortably clears the bar for efficient capital use
16.9%
ROE
Middle ground · Mixed
10.2%
Debt / equity
Favorable · 0.03 - strong leverage
0.03x
Current ratio
Reasonable · Just enough on hand to cover near-term bills
1.40x
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $12.88B | 31.4 | +4.4% | 65 | |
| $11.53B | 22.0 | +19.7% | 78 | |
| $4.60B | 13.9 | +13.5% | 77 | |
| $33.87B | 35.4 | +15.5% | 77 | |
| $1.11T | 40.1 | +49.6% | 76 |